Skip to main content

Table 2 Baseline and changes from baseline scores for Patient-Reported Outcomes by group

From: Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research

 

Yoga Group (n = 27)

Control Group (n = 21)

 
  

Mean (SD)

Mean (SD)

d a

NIH Patient Reported Outcomes Measurement Information System Outcomes

Anxiety

 Baseline

54.0 (7.8)

50.2 (8.6)

–

 Change from baseline, wk. 7

−2.1 (5.0)

−0.7 (5.4)

− 0.27

 Change from baseline, wk. 12

−3.1 (5.7)

−1.3 (7.1)

−0.30

 Change from baseline, wk. 16

−4.2 (5.0)

−2.0 (7.2)

− 0.37

Depression

 Baseline

49.3 (7.9)

45.2 (6.0)

–

 Change from baseline, wk. 7

−3.7 (6.3)

0.3 (5.4)

−0.64

 Change from baseline, wk. 12

−3.8 (5.4)

1.6 (7.7)

− 0.78

 Change from baseline, wk. 16

−4.4 (7.0)

−0.6 (7.1)

−0.53

Interest Sexual Activity

 Baseline

43.0 (6.8)

43.8 (8.0)

–

 Change from baseline, wk. 7

−0.6 (5.8)

− 0.2 (4.6)

− 0.08

 Change from baseline, wk. 12

0.4 (4.9)

2.4 (4.2)

−0.43

 Change from baseline, wk. 16

0.7 (5.0)

−0.4 (6.9)

0.20

Mental Health

 Baseline

45.1 (5.1)

41.1 (5.0)

–

 Change from baseline, wk. 7

−5.0 (7.2)

− 5.3 (5.0)

0.05

 Change from baseline, wk. 12

−5.1 (5.0)

−4.8 (6.5)

−0.05

 Change from baseline, wk. 16

−5.2 (4.2)

−4.8 (5.0)

−0.11

Orgasm

 Baseline

2.9 (1.9)

3.0 (1.6)

–

 Change from baseline, wk. 7

0.0 (1.6)

0.6 (1.6)

−0.37

 Change from baseline, wk. 12

−0.2 (0.6)

0.1 (2.0)

−0.16

 Change from baseline, wk. 16

−0.3 (0.8)

0.2 (1.9)

−0.35

Pain Intensity

 Baseline

45.1 (8.6)

40.4 (9.0)

–

 Change from baseline, wk. 7

−1.6 (5.8)

0.6 (7.5)

−0.34

 Change from baseline, wk. 12

−2.4 (7.0)

0.6 (6.6)

−0.43

 Change from baseline, wk. 16

−3.2 (7.3)

0.8 (8.4)

−0.51

Physical Health

 Baseline

39.8 (3.1)

40.0 (4.4)

–

 Change from baseline, wk. 7

−6.3 (6.2)

−7.2 (6.8)

0.14

 Change from baseline, wk. 12

−6.6 (6.0)

−3.5 (5.7)

−0.52

 Change from baseline, wk. 16

−6.9 (7.3)

−6.9 (6.9)

0.01

Satisfaction Sex Life

 Baseline

49.1 (12.6)

46.7 (12.8)

–

 Change from baseline, wk. 7

−1.0 (10.4)

2.4 (6.0)

−0.38

 Change from baseline, wk. 12

−0.9 (6.6)

2.9 (12.6)

−0.41

 Change from baseline, wk. 16

−1.7 (8.2)

−0.3 (11.4)

−0.15

Vaginal Discomfort

 Baseline

48.0 (5.9)

48.0 (4.3)

–

 Change from baseline, wk. 7

0.7 (4.0)

−1.5 (3.8)

0.55

 Change from baseline, wk. 12

0.5 (4.1)

−1.5 (5.6)

0.43

 Change from baseline, wk. 16

−0.8 (3.2)

−2.3 (1.7)

0.51

Sleep

 Baseline

50.1 (6.2)

48.8 (6.7)

–

 Change from baseline, wk. 7

−2.3 (5.8)

0.2 (5.2)

−0.44

 Change from baseline, wk. 12

−2.5 (5.9)

1.0 (4.7)

−0.61

 Change from baseline, wk. 16

−3.8 (7.6)

−2.1 (5.0)

−0.26

Quality of Life

 Baseline (1–5)

3.1 (0.8)

2.6 (0.9)

–

 Change from baseline, wk. 7

−0.4 (0.6)

−0.4 (0.8)

0.10

 Change from baseline, wk. 12

−0.1 (0.5)

−0.3 (0.9)

0.34

 Change from baseline, wk. 16

−0.2 (0.5)

−0.3 (0.9)

0.09

MPN Symptom Assessment Form Outcomes

Fatigue

 Baseline (0–10)

5.4 (2.3)

4.5 (2.8)

–

 Change from baseline, wk. 7

−0.7 (2.5)

−0.8 (3.1)

0.02

 Change from baseline, wk. 12

−0.5 (2.2)

−0.6 (2.3)

0.06

 Change from baseline, wk. 16

−0.7 (2.4)

0.6 (2.0)

−0.56

Total Symptom Score

 Baseline (0–100)

28.7 (15.6)

21.9 (13.5)

–

 Change from baseline, wk. 7

−1.4 (9.5)

−5.8 (11.2)

0.44

 Change from baseline, wk. 12

−2.7 (8.5)

−4.1 (9.5)

0.15

 Change from baseline, wk. 16

4.4 (8.8)

7.1 (8.7)

−0.31

  1. Note: lower scores represent an improvement for each measured outcome. NIH PROMIS outcomes are converted to standardized t-scores
  2. acohen’s d was used for effect sizes